View Scopus Profile

Linda C Laux

Associate Professor, Pediatrics

Emaill-laux@northwestern.edu

1735 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Grants

8 Active
13 Finished

13 results

Filter

Finished

A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care (Cohort 1), Followed by a Randomized, Double-blind, Placebo

Zogenix International Limited

4/4/17 → 4/3/20

Project: Research project

ZX008-1503: An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children and Young Adults with Dravet Syndrome

Zogenix International Limited

3/6/17 → 3/5/20

Project: Research project

ZX008-1501: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children and Young Adults with Dravet S

Zogenix International Limited

5/1/16 → 3/20/19

Project: Research project

ZX008-1501: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children and Young Adults with Dravet S

Zogenix International Limited

5/1/16 → 3/20/19

Project: Research project

ZX008-1501: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children and Young Adults with Dravet S

Zogenix International Limited

5/1/16 → 3/20/19

Project: Research project

1424: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P) in children and young adults with Dravet syndrome.

GW Research Ltd

3/1/16 → 2/28/17

Project: Research project

Epidiolex as a New Treatment for Drug Resistant Epilepsies

GW Research Ltd

9/25/15 → 1/31/18

Project: Research project

GWEP1423: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in children and

GW Research Ltd

7/15/15 → 11/29/18

Project: Research project

GWEP1415: An open label extension study to investigate the safety of cannabidiol (GWP42003-P; CBD) in children and adults with inadequately controlled Dravet or Lennox-Gastaut Syndromes

GW Research Ltd

6/1/15 → 4/18/19

Project: Research project

GWEP1332: A double-blind, placebo-controlled, two-part study to investigate the dose-ranging safety and pharmacokinetics, followed by the efficacy and safety of Cannabidiol (GWP42003-P) in children and young adults with Dravet

GW Research Ltd

10/27/14 → 11/29/18

Project: Research project

Epidiolex as a New Treatment for Drug Resistant Epilepsies

Northwestern University

9/1/14 → 8/31/15

Project: Research project

Dravet Syndrome Database

Dravet Syndrome Foundation

9/1/13 → 9/30/14

Project: Research project

Dravet Syndrome Genome Sequencing

Intellimedix LLC

10/8/12 → 12/31/13

Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.